The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
Hoffmann, V S, Baccarani, M, Hasford, J, Lindoerfer, D, Burgstaller, S, Sertic, D, Costeas, P, Mayer, J, Indrak, K, Everaus, H, Koskenvesa, P, Guilhot, J, Schubert-Fritschle, G, Castagnetti, F, Di Raimondo, F, Lejniece, S, Griskevicius, L, Thielen, N, Sacha, T, Hellmann, A, Turkina, A G, Zaritskey, A, Bogdanovic, A, Sninska, Z, Zupan, I, Steegmann, J-L, Simonsson, B, Clark, R E, Covelli, A, Guidi, G, Hehlmann, R
Published in Leukemia (01.06.2015)
Published in Leukemia (01.06.2015)
Get full text
Journal Article
Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A, Hehlmann, R
Published in Leukemia (01.03.2017)
Published in Leukemia (01.03.2017)
Get full text
Journal Article
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Ilander, M, Olsson-Strömberg, U, Schlums, H, Guilhot, J, Brück, O, Lähteenmäki, H, Kasanen, T, Koskenvesa, P, Söderlund, S, Höglund, M, Markevärn, B, Själander, A, Lotfi, K, Dreimane, A, Lübking, A, Holm, E, Björeman, M, Lehmann, S, Stenke, L, Ohm, L, Gedde-Dahl, T, Majeed, W, Ehrencrona, H, Koskela, S, Saussele, S, Mahon, F-X, Porkka, K, Hjorth-Hansen, H, Bryceson, Y T, Richter, J, Mustjoki, S
Published in Leukemia (01.05.2017)
Published in Leukemia (01.05.2017)
Get full text
Journal Article
Safety and efficacy of the combination of pegylated interferon- alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
Hjorth-Hansen, H, Stentoft, J, Richter, J, Koskenvesa, P, Hoglund, M, Dreimane, A, Porkka, K, Gedde-Dahl, T, Gjertsen, B T, Gruber, F X, Stenke, L, Eriksson, K M, Markevaern, B, Luebking, A, Vestergaard, H, Udby, L, Bjerrum, O W, Persson, I, Mustjoki, S, Olsson-Stromberg, U
Published in Leukemia (01.09.2016)
Published in Leukemia (01.09.2016)
Get full text
Journal Article
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
Hjorth-Hansen, H, Stentoft, J, Richter, J, Koskenvesa, P, Höglund, M, Dreimane, A, Porkka, K, Gedde-Dahl, T, Gjertsen, B T, Gruber, F X, Stenke, L, Eriksson, K M, Markevärn, B, Lübking, A, Vestergaard, H, Udby, L, Bjerrum, O W, Persson, I, Mustjoki, S, Olsson-Strömberg, U
Published in Leukemia (01.09.2016)
Published in Leukemia (01.09.2016)
Get full text
Journal Article
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
Mustjoki, S, Richter, J, Barbany, G, Ehrencrona, H, Fioretos, T, Gedde-Dahl, T, Gjertsen, B T, Hovland, R, Hernesniemi, S, Josefsen, D, Koskenvesa, P, Dybedal, I, Markevärn, B, Olofsson, T, Olsson-Strömberg, U, Rapakko, K, Thunberg, S, Stenke, L, Simonsson, B, Porkka, K, Hjorth-Hansen, H
Published in Leukemia (01.07.2013)
Published in Leukemia (01.07.2013)
Get full text
Journal Article
Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph(+)CD34(+)CD38(neg)) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy
Mustjoki, S, Rohon, P, Rapakko, K, Jalkanen, S, Koskenvesa, P, Lundán, T, Porkka, K
Published in Leukemia (01.01.2010)
Published in Leukemia (01.01.2010)
Get full text
Journal Article
Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph CD34 CD38 ) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy
MUSTJOKI, S, ROHAN, P, RAPAKKO, K, JALKANEN, S, KOSKENVESA, P, LUNDAN, T, PORKKA, K
Published in Leukemia (2010)
Published in Leukemia (2010)
Get full text
Journal Article
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
Pietarinen, P O, Pemovska, T, Kontro, M, Yadav, B, Mpindi, J P, Andersson, E I, Majumder, M M, Kuusanmäki, H, Koskenvesa, P, Kallioniemi, O, Wennerberg, K, Heckman, C A, Mustjoki, S, Porkka, K
Published in Blood cancer journal (New York) (01.05.2015)
Published in Blood cancer journal (New York) (01.05.2015)
Get full text
Journal Article
Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML
Brück, Oscar, Blom, Sami, Dufva, Olli, Turkki, Riku, Chheda, Himanshu, Ribeiro, Antonio, Kovanen, Panu, Aittokallio, Tero, Koskenvesa, Perttu, Kallioniemi, Olli, Porkka, Kimmo, Pellinen, Teijo, Mustjoki, Satu
Published in Leukemia (01.07.2018)
Published in Leukemia (01.07.2018)
Get full text
Journal Article
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
Flygt, Hjalmar, Söderlund, Stina, Richter, Johan, Saussele, Susanne, Koskenvesa, Perttu, Stenke, Leif, Mustjoki, Satu, Dimitrijevic, Andreja, Stentoft, Jesper, Majeed, Waleed, Roy, Lydia, Wolf, Dominik, Dreimane, Arta, Gjertsen, Bjørn Tore, Gedde-Dahl, Tobias, Ahlstrand, Erik, Markevärn, Berit, Hjorth-Hansen, Henrik, Janssen, Jeroen, Olsson-Strömberg, Ulla
Published in Leukemia (2024)
Published in Leukemia (2024)
Get full text
Journal Article
Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
Flygt, Hjalmar, Söderlund, Stina, Richter, Johan, Saussele, Susanne, Koskenvesa, Perttu, Stenke, Leif, Mustjoki, Satu, Dimitrijevic, Andreja, Stentoft, Jesper, Majeed, Waleed, Roy, Lydia, Wolf, Dominik, Dreimane, Arta, Gjertsen, Bjørn Tore, Gedde-Dahl, Tobias, Ahlstrand, Erik, Markevärn, Berit, Hjorth-Hansen, Henrik, Janssen, Jeroen, Olsson-Strömberg, Ulla
Published in Leukemia (01.04.2024)
Published in Leukemia (01.04.2024)
Get full text
Journal Article
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI
Richter, Johan, Lübking, Anna, Söderlund, Stina, Lotfi, Kourosh, Markevärn, Berit, Själander, Anders, Stenke, Leif, Deneberg, Stefan, Ahlstrand, Erik, Myhr-Eriksson, Kristina, Panayiotidis, Panayiotis, Gedde-Dahl, Tobias, Žáčková, Daniela, Mayer, Jiří, Olsson-Strömberg, Ulla, Mahon, Francois-Xavier, Saussele, Susanne, Hjorth-Hansen, Henrik, Koskenvesa, Perttu
Published in Leukemia (01.08.2021)
Published in Leukemia (01.08.2021)
Get full text
Journal Article
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
Huuhtanen, Jani, Ilander, Mette, Yadav, Bhagwan, Dufva, Olli M.J., Lähteenmäki, Hanna, Kasanen, Tiina, Klievink, Jay, Olsson-Strömberg, Ulla, Stentoft, Jesper, Richter, Johan, Koskenvesa, Perttu, Höglund, Martin, Söderlund, Stina, Dreimane, Arta, Porkka, Kimmo, Gedde-Dahl, Tobias, Gjertsen, Björn T., Stenke, Leif, Myhr-Eriksson, Kristina, Markevärn, Berit, Lübking, Anna, Dimitrijevic, Andreja, Udby, Lene, Bjerrum, Ole Weis, Hjorth-Hansen, Henrik, Mustjoki, Satu
Published in The Journal of clinical investigation (01.09.2022)
Published in The Journal of clinical investigation (01.09.2022)
Get full text
Journal Article
Carfilzomib, Elotuzumab and Dexamethasone for Relapsed or Refractory Myeloma Patients
Silvennoinen, Raija Helena, Nahi, Hareth, Anttila, Pekka, Koskenvesa, Perttu, Lievonen, Juha, Marttila, Anu, Varmavuo, Ville, Sikiö, Anu, Nurmi, Marita, Säily, Marjaana, Partanen, Anu, Sankelo, Marja, Luoma, Sini, Mäntymaa, Pentti, Ilveskero, Sorella, Rode Eshoj, Henrik, Nielsen, Lene Kongsgaard, Jantunen, Esa, Heckman, Caroline A
Published in BLOOD (05.11.2020)
Published in BLOOD (05.11.2020)
Get full text
Journal Article
Conference Proceeding
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
Hjorth-Hansen, Henrik, Stenke, Leif, Söderlund, Stina, Dreimane, Arta, Ehrencrona, Hans, Gedde-Dahl, Tobias, Gjertsen, Bjørn Tore, Höglund, Martin, Koskenvesa, Perttu, Lotfi, Kourosh, Majeed, Waleed, Markevärn, Berit, Ohm, Lotta, Olsson-Strömberg, Ulla, Remes, Kari, Suominen, Merja, Simonsson, Bengt, Porkka, Kimmo, Mustjoki, Satu, Richter, Johan
Published in European journal of haematology (01.03.2015)
Published in European journal of haematology (01.03.2015)
Get full text
Journal Article
Long‐term tolerability and efficacy after initial PegIFN‐α addition to dasatinib in CML‐CP: Five‐year follow‐up of the NordCML007 study
Flygt, Hjalmar, Söderlund, Stina, Stentoft, Jesper, Richter, Johan, Koskenvesa, Perttu, Mustjoki, Satu, Majeed, Waleed, Lübking, Anna, Dreimane, Arta, Markevärn, Berit, Stenke, Leif, Myhr Eriksson, Kristina, Gjertsen, Bjørn Tore, Gedde‐Dahl, Tobias, Dimitrijevic, Andreja, Udby, Lene, Olsson‐Strömberg, Ulla, Hjorth‐Hansen, Henrik
Published in European journal of haematology (01.12.2021)
Published in European journal of haematology (01.12.2021)
Get full text
Journal Article
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia
Rajala, Hanna L. M., Missiry, Mohamed El, Ruusila, Anniina, Koskenvesa, Perttu, Brümmendorf, Tim H., Gjertsen, Bjorn T., Janssen, Jeroen, Lotfi, Kourosh, Markevärn, Berit, Olsson-Strömberg, Ulla, Stenke, Leif, Stentoft, Jesper, Richter, Johan, Hjorth-Hansen, Henrik, Kreutzman, Anna, Mustjoki, Satu
Published in Journal of cancer research and clinical oncology (01.08.2017)
Published in Journal of cancer research and clinical oncology (01.08.2017)
Get full text
Journal Article
Chronic myeloid leukemia patients' adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians
Kekäle, Meri, Talvensaari, Kimmo, Koskenvesa, Perttu, Porkka, Kimmo, Airaksinen, Marja
Published in Patient preference and adherence (01.01.2014)
Published in Patient preference and adherence (01.01.2014)
Get full text
Journal Article
Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment
Kreutzman, Anna, Koskenvesa, Perttu, Tiina, Kasanen, Olsson-Strömberg, Ulla, Stentoft, Jesper, Stenke, Leif, Udby, Lene, Gjertsen, Bjorn T., Lotfi, Kourosh, Markevän, Berit, Janssen, Jeroen, Brümmendorf, Tim, Richter, Johan, Hjorth-Hansen, Henrik, Mustjoki, Satu
Published in BLOOD (02.12.2016)
Published in BLOOD (02.12.2016)
Get full text
Journal Article
Conference Proceeding